Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The GAA repeat expansion in the FXN gene refers to an abnormal increase in the number of consecutive GAA trinucleotide repeats located within intron 1 of the frataxin (FXN) gene. This expansion leads to transcriptional silencing of FXN, resulting in reduced frataxin protein levels and Friedreich's ataxia (FRDA).
N/A
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on GAA Repeat Expansion in FXN Gene (GAA Expansion (FXN)).